New learning discoveries about 43142-76-3

There are many compounds similar to this compound(43142-76-3)Related Products of 43142-76-3. if you want to know more, you can check out my other articles. I hope it will help you,maybe you’ll find some useful information.

Related Products of 43142-76-3. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: Ethyl 5-chloro-3-formyl-1H-indole-2-carboxylate, is researched, Molecular C12H10ClNO3, CAS is 43142-76-3, about Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity. Author is Mohamed, Fatma A. M.; Gomaa, Hesham A. M.; Hendawy, O. M.; Ali, Asmaa T.; Farghaly, Hatem S.; Gouda, Ahmed M.; Abdelazeem, Ahmed H.; Abdelrahman, Mostafa H.; Trembleau, Laurent; Youssif, Bahaa G. M..

New EGFR inhibitor series of fifteen 5-chloro-3-hydroxymethyl-indole-2-carboxamide derivatives I (R1, R2 = H, Me; R3 = Me2N, pyrrolidin-1-yl, piperidin-1-yl, etc., R4 = H; R3 = H, R4 = pyrrolidin-1-yl, morpholin-4-yl, etc.) and II [R5 = 1-benzylpiperidin-3-yl, 1-benzylpyrrolidin-3-yl, 2-(morpholin-4-yl)ethyl] has been designed, synthesized, and tested for antiproliferative activity against a panel of cancer cell lines. The results showed that p-substituted phenethyl derivatives showed superior antiproliferative activity compared to their m-substituted counterparts. Compounds I (R1 = R2 = R4 = H; R3 = piperidin-1-yl, morpholin-4-yl) and I (R1 = R2 = R3 = H; R4 = piperidin-1-yl, morpholin-4-yl) displayed promising EGFR inhibitory activity as well as an increase in caspase 3 levels. Compounds I (R1 = R2 = R4 = H; R3 = piperidin-1-yl, 4-morpholin-4-yl) increased caspase-8 and 9 levels, as well as inducing Bax and decreasing Bcl-2 protein levels. The compound I (R1 = R2 = R4 = H; R3 = morpholin-4-yl) demonstrated cell cycle arrest at pre-G1 and G2/M phases. The results of the docking study into the active site of EGFR revealed strong fitting of the new compounds with higher binding affinities compared to erlotinib.

There are many compounds similar to this compound(43142-76-3)Related Products of 43142-76-3. if you want to know more, you can check out my other articles. I hope it will help you,maybe you’ll find some useful information.

Reference:
Chiral Catalysts,
Chiral catalysts – SlideShare